Tag: China Covid19 Vaccine

Two doses of CoronaVac, a Covid-19 vaccine manufactured by Chinese firm Sinovac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a results of phase 1/2 clinical trial published in The Lancet Infectious Diseases journal.

Beijing: An inactivated Covid19 vaccine candidate has shown promising results in both safety and efficacy in phase 1 and phase 2 clinical trials, according to the China National Pharmaceutical Group (Sinopharm). The vaccine, developed by the Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to Sinopharm, involved 1,120 volunteers aged […]